From: Prognostic and clinical significance of HER-2 low expression in early-stage gastric cancer
Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
HR | 95%CI | P | HR | 95%CI | P | |
Age(≥ 60 vs < 60) | 0.85 | 0.47–1.51 | 0.484 | |||
Sex (M vs F) | 1.35 | 0.72–2.52 | 0.377 | |||
Differentiation (Poor vs Well) | 1.93 | 1.08–3.45 | 0.044 | |||
Tumor invasion (T1-2 vs T3-4) | 0.15 | 0.08–0.28 | 0.001 | 4.20 | 0.98–18.00 | 0.053 |
Lymph node (N0 vs N +) | 0.08 | 0.04–0.14 | < 0.001 | 3.56 | 1.87–4.25 | 0.038 |
TNM stage (I-II vs III) | 0.21 | 0.12–0.37 | < 0.001 | 4.88 | 2.03–11.71 | 0.000 |
Ki-67 index (Low vs High) | 0.76 | 0.40–1.45 | 0.402 | |||
Her-2 (0 vs Low) | 0.90 | 0.47–1.70 | 0.741 |